Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer.

Br J Cancer · 2017 · PMC5355924 · PMID 28183138

Europe PMC DOI

hedged sentence

0.0810

closest p · 1.6× alpha

0.0810

boldest claim

The sentences

borderline significanceP =0.081so close (0.05 < p ≤ 0.1)

However, the prognostic effect of receiving a neoadjuvant/adjuvant platinum treatment demonstrated borderline significance (HR 0.54, CI 0.27–1.08, P =0.081).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.